Challenges in using circulating miRNAs as cancer biomarkers

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Tiberio, Paola ^a   Callari, Maurizio ^a   Angeloni, Valentina ^a   Daidone, Maria Grazia ^a   Appierto, Valentina ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; RNA; TUMOR MARKER;

BODY FLUID; DATA ANALYSIS; EXTRACTION; HEMOLYSIS; HUMAN; HYBRIDIZATION; MICROARRAY ANALYSIS; PLASMA; REVIEW; SERUM; BLOOD; NEOPLASMS; PATHOLOGY;

BIOMARKERS, TUMOR; HUMANS; MICRORNAS; NEOPLASMS; RNA, NEOPLASM;

EID: 84927153580     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/731479     Document Type: Review

References (77)

1. V. Ambros, "microRNAs: tiny regulators with great potential", Cell, vol. 107, no. 7, pp. 823-826, 2001.
2. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell, vol. 116, no. 2, pp. 281-297, 2004.
3. A. Kozomara and S. Griffiths-Jones, "MiRBase: Annotating high confidence microRNAs using deep sequencing data", Nucleic Acids Research, vol. 42, no. 1, pp. D68-D73, 2014.
4. D. P. Bartel, "MicroRNAs: target recognition and regulatory functions", Cell, vol. 136, no. 2, pp. 215-233, 2009.
5. J. Krol, I. Loedige, and W. Filipowicz, "The widespread regulation of microRNA biogenesis, function and decay", Nature Reviews Genetics, vol. 11, no. 9, pp. 597-610, 2010.
6. L. de Cecco, M. Dugo, S. Canevari, M. G. Daidone, and M. Callari, "Measuring microRNA expression levels in oncology: from samples to data analysis", Critical Reviews in Oncogenesis, vol. 18, no. 4, pp. 273-287, 2013.
7. R. Visone and C. M. Croce, "MiRNAs and cancer", The American Journal of Pathology, vol. 174, no. 4, pp. 1131-1138, 2009.
8. C. M. Croce, "Causes and consequences of microRNA dysregulation in cancer", Nature Reviews Genetics, vol. 10, no. 10, pp. 704-714, 2009.
9. G. Di Leva and C. M. Croce, "miRNA profiling of cancer", Current Opinion in Genetics & Development, vol. 23, no. 1, pp. 3-11, 2013.
10. M. A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A. K. Sood, and G. A. Calin, "MicroRNAs in body fluids-the mix of hormones and biomarkers", Nature Reviews Clinical Oncology, vol. 8, no. 8, pp. 467-477, 2011.
11. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells", Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
12. D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-Lawson et al., "Functional delivery of viral miRNAs via exosomes", Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6328-6333, 2010.
13. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al., "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
14. K. Wang, S. Zhang, J. Weber, D. Baxter, and D. J. Galas, "Export of microRNAs and microRNA-protective protein by mammalian cells", Nucleic Acids Research, vol. 38, no. 20, pp. 7248-7259, 2010.
15. K. C. Vickers and A. T. Remaley, "Lipid-based carriers of microRNAs and intercellular communication", Current Opinion in Lipidology, vol. 23, no. 2, pp. 91-97, 2012.
16. M. A. Cortez and G. A. Calin, "MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases", Expert Opinion on Biological Therapy, vol. 9, no. 6, pp. 703-711, 2009.
17. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., "Circulating microRNAs as stable blood-based markers for cancer detection", Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
18. X. Chen, Y. Ba, L. Ma et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases", Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
19. E. K. O. Ng, W. W. S. Chong, H. Jin et al., "Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening", Gut, vol. 58, no. 10, pp. 1375-1381, 2009.
20. W. Zhu, W. Qin, U. Atasoy, and E. R. Sauter, "Circulating microRNAs in breast cancer and healthy subjects", BMC Research Notes, vol. 2, article 89, 2009.
21. A. Allegra, A. Alonci, S. Campo et al., "Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer", International Journal of Oncology, vol. 41, no. 6, pp. 1897-1912, 2012.
22. J. Shen, S. A. Stass, and F. Jiang, "MicroRNAs as potential biomarkers in human solid tumors", Cancer Letters, vol. 329, no. 2, pp. 125-136, 2013.
23. H. Schwarzenbach, N. Nishida, G. A. Calin, and K. Pantel, "Clinical relevance of circulating cell-free microRNAs in cancer", Nature Reviews Clinical Oncology, vol. 11, no. 3, pp. 145-156, 2014.
24. C. H. Lawrie, S. Gal, H. M. Dunlop et al., "Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma", British Journal of Haematology, vol. 141, no. 5, pp. 672-675, 2008.
25. G. Sozzi, M. Boeri, M. Rossi et al., "Clinical utility of a plasmabased miRNAsignature classifierwithin computed tomography lung cancer screening: a correlative MILD trial study", Journal of Clinical Oncology, vol. 32, no. 8, pp. 768-773, 2014.
26. E.-J. Jung, L. Santarpia, J. Kim et al., "Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients", Cancer, vol. 118, no. 10, pp. 2603-2614, 2012.
27. P. Wang, L. Zhuang, J. Zhang et al., "The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL", Molecular Oncology, vol. 7, no. 3, pp. 334-345, 2013.
28. R. S. Leidner, L. Li, and C. L. Thompson, "Dampening enthusiasmfor circulatingmicroRNA in breast cancer", PLoS ONE, vol. 8, no. 3, Article ID e57841, 2013.
29. C. C. Pritchard, E. Kroh, B. Wood et al., "Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies", Cancer Prevention Research, vol. 5, no. 3, pp. 492-497, 2012.
30. J. S. McDonald, D. Milosevic, H. V. Reddi, S. K. Grebe, and A. Algeciras-Schimnich, "Analysis of circulating microRNA: preanalytical and analytical challenges", Clinical Chemistry, vol. 57, no. 6, pp. 833-840, 2011.
31. K. Wang, Y. Yuan, J.-H. Cho, S. McClarty, D. Baxter, and D. J. Galas, "Comparing the MicroRNA spectrum between serum and plasma", PLoS ONE, vol. 7, no. 7, Article ID e41561, 2012.
32. E. M. Kroh, R. K. Parkin, P. S. Mitchell, and M. Tewari, "Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRTPCR)", Methods, vol. 50, no. 4, pp. 298-301, 2010.
33. H. H. Cheng, H. S. Yi, Y. Kim et al., "Plasma processing conditions substantially influence circulating microRNA biomarker levels", PLoS ONE, vol. 8, no. 6, Article ID e64795, 2013.
34. I. Moret, D. Sańchez-Izquierdo, M. Borra et al., "Assessing an improved protocol for plasma microRNA extraction", PLoS ONE, vol. 8, no. 12, Article IDe82753, 2013.
35. O. Fortunato, M. Boeri, C. Verri et al., "Assessment of circulating micrornas in plasma of lung cancer patients", Molecules, vol. 19, no. 3, pp. 3038-3054, 2014.
36. M. Willems, H. Moshage, F. Nevens, J. Fevery, and S. H. Yap, "Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay", Journal of Virological Methods, vol. 42, no. 1, pp. 127-130, 1993.
37. M. E. García, J. L. Blanco, J. Caballero, and D. Gargallo-Viola, "Anticoagulants interfere with PCR used to diagnose invasive aspergillosis", Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1567-1568, 2002.
38. D.-J. Kim, S. Linnstaedt, J. Palma et al., "Plasma components affect accuracy of circulating cancer-related microRNA quantitation", Journal of Molecular Diagnostics, vol. 14, no. 1, pp. 71-80, 2012.
39. P. Tiberio, L. de Cecco, M. Callari, E. Cavadini, M. G. Daidone, and V. Appierto, "MicroRNA detection in plasma samples: how to treat heparinized plasma", The Journal of Molecular Diagnostics, vol. 15, no. 1, p. 138, 2013.
40. W. Cui, J. Ma, Y. Wang, and S. Biswal, "Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry", PLoS ONE, vol. 6, no. 8, Article ID e22988, 2011.
41. S. Gilad, E. Meiri, Y. Yogev et al., "Serum microRNAs are promising novel biomarkers", PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008.
42. K. Page, D. S. Guttery, N. Zahra et al., "Influence of plasma processing on recovery and analysis of circulating nucleic acids", PLoS ONE, vol. 8, no. 10, Article IDe77963, 2013.
43. S. Grasedieck, N. Schöler, M. Bommer et al., "Impact of serum storage conditions on microRNA stability", Leukemia, vol. 26, no. 11, pp. 2414-2416, 2012.
44. M. B. Kirschner, S. C. Kao, J. J. Edelman et al., "Haemolysis during sample preparation alters microRNA content of plasma", PLoS ONE, vol. 6, no. 9, Article ID e24145, 2011.
45. M. B. Kirschner, J. J. B. Edelman, S. C.-H. Kao, M. P. Vallely, N. Van Zandwijk, and G. Reid, "The impact of hemolysis on cellfree microRNA biomarkers", Frontiers in Genetics, vol. 4, article 94, Article ID article 94, 2013.
46. S. O. Sowemimo-Coker, "Red blood cell hemolysis during processing", Transfusion Medicine Reviews, vol. 16, no. 1, pp. 46-60, 2002.
47. V. Appierto, M. Callari, E. Cavadini, D. Morelli, M. G. Daidone, and P. Tiberio, "A lipemia-independent nanodrop-based score to identify hemolysis in plasma and serum samples", Bioanalysis, vol. 6, no. 9, pp. 1215-1226, 2014.
48. T. Blondal, S. J. Nielsen, A. Baker et al., "Assessing sample and miRNA profile quality in serum and plasma or other biofluids", Methods, vol. 59, no. 1, pp. S1-S6, 2013.
49. I. S. Sourvinou, A. Markou, and E. S. Lianidou, "Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability", The Journal of Molecular Diagnostics, vol. 15, no. 6, pp. 827-834, 2013.
50. M. A. McAlexander, M. J. Phillips, and K. W. Witwer, "Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from cerebrospinal fluid", Frontiers in Genetics, vol. 4, article 83, 2013.
51. L. O'Driscoll, "Extracellular nucleic acids and their potential as diagnostic, prognostic and predictive biomarkers", Anticancer Research A, vol. 27, no. 3, pp. 1257-1265, 2007.
52. A. Zampetaki and M. Mayr, "Analytical challenges and technical limitations in assessing circulating MiRNAs", Thrombosis and Haemostasis, vol. 108, no. 4, pp. 592-598, 2012.
53. G. Reid, M. B. Kirschner, and N. van Zandwijk, "Circulating microRNAs: association with disease and potential use as biomarkers", Critical Reviews in Oncology/Hematology, vol. 80, no. 2, pp. 193-208, 2011.
54. M. Callari, M. Dugo, V. Musella et al., "Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues", PLoS ONE, vol. 7, no. 9, Article ID e45105, 2012.
55. A. Git, H. Dvinge, M. Salmon-Divon et al., "Systematic comparison of microarray profiling, real-time PCR, and nextgeneration sequencing technologies for measuring differential microRNA expression", RNA, vol. 16, no. 5, pp. 991-1006, 2010.
56. M. Callari, P. Tiberio, L. de Cecco et al., "Feasibility of circulating miRNA microarray analysis fromarchival plasma samples", Analytical Biochemistry, vol. 437, no. 2, pp. 123-125, 2013.
57. Z. Williams, I. Z. Ben-Dov, R. Elias et al., "Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations", Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 11, pp. 4255-4260, 2013.
58. X. Chen, H. Liang, D. Guan et al., "Acombination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serummicroRNAs", PLoS ONE, vol. 8, no. 11, Article IDe79652, 2013.
59. J. Hu, Z. Wang, B.-Y. Liao et al., "Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients", International Journal of Cancer, vol. 135, no. 5, pp. 1187-1194, 2014.
60. S. Pizzamiglio, S. Bottelli, C. M. Ciniselli et al., "A normalization strategy for the analysis of plasma microRNA qPCR data in colorectal cancer", International Journal of Cancer, vol. 134, no. 8, pp. 2016-2018, 2014.
61. S. Pradervand, J. Weber, J. Thomas et al., "Impact of normalization on miRNA microarray expression profiling", RNA, vol. 15, no. 3, pp. 493-501, 2009.
62. C. Suo, A. Salim, K.-S. Chia, Y. Pawitan, and S. Calza, "Modified least-variant set normalization for miRNA microarray", RNA, vol. 16, no. 12, pp. 2293-2303, 2010.
63. L. X. Garmire and S. Subramaniam, "Evaluation of normalizationmethods inmammalianmicroRNA-Seq data", RNA, vol. 18, no. 6, pp. 1279-1288, 2012.
64. D. Wu, Y. Hu, S. Tong, B. R. G. Williams, G. K. Smyth, and M. P. Gantier, "The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease", RNA, vol. 19, no. 7, pp. 876-888, 2013.
65. M. Boeri, C. Verri, D. Conte et al., "MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer", Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 9, pp. 3713-3718, 2011.
66. H. Zhao, J. Shen, L. Medico, D. Wang, C. B. Ambrosone, and S. Liu, "A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer", PLoS ONE, vol. 5, no. 10, Article ID e13735, 2010.
67. R. Duttagupta, R. Jiang, J. Gollub, R. C. Getts, and K. W. Jones, "Impact of cellular miRNAs on circulating miRNA biomarker signatures", PLoS ONE, vol. 6, no. 6, Article ID e20769, 2011.
68. Y. T. Wang, P. C. Tsai, Y. C. Liao, C. Y. Hsu, and S. H. Juo, "Circulating microRNAs have a sex-specific association with metabolic syndrome", Journal of Biomedical Science, vol. 20, no. 1, article 72, 2013.
69. H. C. de Boer, C. Van Solingen, J. Prins et al., "Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease", European Heart Journal, vol. 34, no. 44, pp. 3451-3457, 2013.
70. S. Badrnya, R. Baumgartner, and A. Assinger, "Smoking alters circulating plasma microvesicle pattern and microRNA signatures", Thrombosis and Haemostasis, vol. 112, article 1, 2014.
71. S. A. Ross and C. D. Davis, "MicroRNA, nutrition, and cancer prevention", Advances in Nutrition, vol. 2, no. 6, pp. 472-485, 2011.
72. K. W. Witwer, "XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles", RNA Biology, vol. 9, no. 9, pp. 1147-1154, 2012.
73. W. Aoi and K. Sakuma, "Does regulation of skeletal muscle function involve circulating microRNAs?" Frontiers in Physiology, vol. 5, article 39, 2014.
74. M. Marcinkowska, M. Szymanski, W. J. Krzyzosiak, and P. Kozlowski, "Copy number variation of microRNA genes in the human genome", BMC Genomics, vol. 12, article 183, 2011.
75. S. Persengiev, I. Kondova, and R. Bontrop, "Insights on the functional interactions between miRNAs and copy number variations in the aging brain", Frontiers in Molecular Neuroscience, vol. 6, article 32, 2013.
76. Y. Qiao, C. Badduke, E. Mercier, S. M. E. Lewis, P. Pavlidis, and E. Rajcan-Separovic, "MiRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability", BMC Genomics, vol. 14, no. 1, article 544, 2013.
77. N. Becker and C. M. Lockwood, "Pre-analytical variables in miRNA analysis", Clinical Biochemistry, vol. 46, no. 10-11, pp. 861-868, 2013.